416
Views
9
CrossRef citations to date
0
Altmetric
Research Article

In silico hit optimization toward AKT inhibition: fragment-based approach, molecular docking and molecular dynamics study

, , , & ORCID Icon
Pages 4301-4311 | Received 29 Jun 2018, Accepted 30 Oct 2018, Published online: 29 Jan 2019

References

  • Addie, M., Ballard, P., Buttar, D., Crafter, C., Currie, G., Davies, B. R., … Ruston, L. (2013). Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases. Journal of Medicinal Chemistry, 56(5), 2059–2073.
  • Benkert, P., Biasini, M., & Schwede, T. (2011). Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics, 27(3), 343–350.
  • Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., …. Overington, J. P. (2014). The ChEMBL bioactivity database: An update. Nucleic Acids Research, 42(D1), 1083–1090.
  • Berendsen, H., Postma, J., Van-Gunsteren, W., DiNola, A., & Haak, J. (1984). Molecular dynamics with coupling to an external bath. Journal of Chemical Physics, 81(8), 3684–3690.
  • Best, R., & Hummer, G. (2009). Optimized molecular dynamics force fields applied to the helix–coil transition of polypeptides. Journal of Physical Chemistry B, 113(26), 9004–9015.
  • Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., … Schwede, T. (2014). SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research, 42(W1), W252–W258.
  • Chen, V. B., Arendall 3rd, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., … Richardson, D. C. (2010). MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallographica Section D Biological Crystallography, D66(1), 12–21.
  • DataWarrior User Manual. (2018). Retrieved May 5, 2018, from http://www.openmolecules.org/help/chemistry.html
  • Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., … Richardson, D. C. (2007). MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Research, 35(Web Server), W375–W383.
  • Fogh, R. H., Boucher, W., Vranken, W. F., Pajon, A., Stevens, T. J., Bhat, T. N., … Laue, E. D. (2005). A framework for scientific data modeling and automated software development. Bioinformatics, 21(8), 1678–1684.
  • Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749.
  • Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews. Drug Discovery, 4(12), 988–1004.
  • Hernández-Campos, A., Velázquez-Martínez, I., Castillo, R., López-Vallejo, F., Jia, P., Yu, Y., … Medina-Franco, J. (2010). Docking of protein kinase B inhibitors: Implications in the structure‐based optimization of a novel scaffold. Chemical Biology & Drug Design, 76(3), 269–276.
  • Homeyer, N., & Gohlke, H. (2012). Free energy calculations by the molecular mechanics Poisson–Boltzmann surface area method. Molecular Informatics, 31(2), 114–122.
  • Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. PROTEINS: Structure, Function, and Bioinformatics, 65(3), 712–725.
  • Hou, T., Wang, J., Li, Y., & Wang, W. (2011). Assessing the performance of the MM/PBSA and MM/GBSA methods: I. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling, 51(1), 69–82.
  • Huck, B., & Mochalkin, I. (2017). Recent progress towards clinically relevant ATP-competitive Akt inhibitors. Bioorganic & Medicinal Chemistry Letters, 27(13), 2838–2848.
  • Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. Journal of Chemical Physics, 79(2), 926–935.
  • Kumari, R., Kumar, R., Open Source Drug Discovery Consortium., & Lynn, A. (2014). g_mmpbsa – A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962.
  • Liby, T. A., Spyropoulos, P., Buff Lindner, H., Eldridge, J., Beeson, C., Hsu, T., & Muise-Helmericks, R. C. (2012). Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells. International Journal of Cancer, 130(3), 532–543.
  • Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side‐chain torsion potentials for the Amber ff99SB protein force field. PROTEINS: Structure, Function, and Bioinformatics, 78(8), 1950–1958.
  • Liu, J., Chen, X., Ward, T., Pegram, M., & Shen, K. (2016). Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer. Tumor Biology, 37(7), 9825–9835.
  • Liu, L., & Dong, X. (2014). Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells. PLos One, 9(10), e108780.
  • Ma, L., Fu, Q., Xu, B., Zhou, H., Gao, J., Shao, X., … Lyu, J. (2018). Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation. International Journal of Cancer, 142(9), 1786–1796.
  • Manning, B., & Cantley, L. (2007). AKT/PKB signaling: Navigating downstream. Cell, 129(7), 1262–1274.
  • Medina-Franco, J., Giulianotti, M. A., Yu, Y., Shen, L., Yao, L., & Singh, N. (2009). Discovery of a novel protein kinase B inhibitor by structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters, 19(16), 4634–4638.
  • Millis, S. Z., Ikeda, S., Reddy, S., Gatalica, Z., & Kurzrock, R. (2016). Landscape of phosphatidylinositol-3-kinase pathway alterations across 19 784 diverse solid tumors. JAMA Oncology, 2(12), 1565–1573.
  • Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791.
  • Nilges, M., Bernard, A., Bardiaux, B., Malliavin, T., Habeck, M., & Rieping, W. (2008). Accurate NMR structures through minimization of an extended hybrid energy. Structure, 16(9), 1305–1312.
  • Parrinello, M., & Rahman, A. (1980). Crystal structure and pair potentials: A molecular-dynamics study. Physical Review Letters, 45(14), 1196–1199.
  • Rieping, W., Habeck, M., Bardiaux, B., Bernard, A., Malliavin, T. E., & Nilges, M. (2007). ARIA2: Automated NOE assignment and data integration in NMR structure calculation. Bioinformatics, 23(3), 381–382.
  • Šali, A., & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234(3), 779–815.
  • Sander, T., Freyss, J., von Korff, M., & Rufener, C. (2015). DataWarrior: An open-source program for chemistry aware data visualization and analysis. Journal of Chemical Information and Modeling, 55(2), 460–473.
  • Sanner, M. F. (1999). Python: A programming language for software integration and development. Journal of Molecular Graphics & Modelling, 17(1), 57–61.
  • Schrödinger release 2015-4. (2015). Glide version 6.9. New York, NY: Schrödinger, LLC.
  • Schrödinger release 2015-4. (2015). Maestro version 10.4. New York, NY: Schrödinger, LLC.
  • Schrödinger release 2015-4. (2015). Prime version 4.2. New York, NY: Schrödinger, LLC.
  • Schrödinger release 2015-4. (2015). Protein Preparation Wizard; Epik version 3.4. New York, NY: Schrödinger, LLC.
  • Sousa Da Silva, A., & Vranken, W. F. (2012). ACPYPE – AnteChamber PYthon Parser interfacE. BMC Research Notes, 5(1), 367.
  • Testa, J. R., & Tsichlis, P. N. (2005). AKT signaling in normal and malignant cells. Oncogene, 24(50), 7391–7393.
  • The UniProt Consortium. (2016). UniProt: The universal protein knowledgebase. Nucleic Acids Research, 45(D1), D158–D169.
  • Vranken, W. F., Boucher, W., Stevens, T. J., Fogh, R. H., Pajon, A., Llinas, M., … Laue, E. D. (2005). The CCPN data model for NMR spectroscopy: Development of a software pipeline. PROTEINS: Structure, Function, and Bioinformatics, 59(4), 687–696.
  • Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174.
  • Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics & Modelling, 25(2), 247–260.
  • Wavefunction Inc. (2010). Spartan version 10. Irvine, CA: Wavefunction Inc.
  • WHO – Cancer. (2018). Retrieved October 2, 2018, from http://www.who.int/en/news-room/fact-sheets/detail/cancer
  • Yang, J., Cron, P., Good, V. M., Thompson, V., Hemmings, B. A., & Barford, D. (2002). Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP–PNP. Nature Structural & Molecular Biology, 9, 940–944.
  • Zhu, L., Derijard, B., Chakrabandhu, K., Wang, B. S., Chen, H. Z., & Hueber, A. O. (2014). Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death. Cancer Letters, 354(2), 355–364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.